drugset / Trial / NCT01816464
Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women
Phase 4
Completed
150 enrolled
University of Witwatersrand, South Africa
Bill and Melinda Gates Foundation · collab
NaSingle-groupOpen-labelBasic science
Summary
The overall aim of this project is to evaluate the immunogenicity of TIV vaccination in HIV-uninfected pregnant women compared with HIV-uninfected non-pregnant women in 2013. Safety data will also be collected.THe Pregnancy outcomes and the transplacental transfer of antibodies will also be assessed.
Timeline
- Start
- 2013-09
- Primary completion
- 2014-02
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | 0.5 ml | Other |